Title: A Systematic Review of the Safety and Efficacy of Electroanalgesia: Focus on Quantum Re-Generation Technology
Introduction
Electroanalgesia, a unique and innovative technology, offers a novel approach to treating pain and acting at the muscular level with decontraction action. This is achieved through the emission of high-tension depolarizing microcurrents. This technology has a therapeutic effect on acute chronic and post-traumatic pain, and it also exhibits anti-inflammatory and decontraction properties.
The mechanism of action is based on the Gate Control Theory, allowing for the inhibition of nociceptive afferent transmission that occurs through small-diameter fibers. This is achieved through the use of pulsed microcurrents with a time duration of one millionth of a second per impulse, acting on the muscular tissue and exhibiting decontraction and increasing tissue oxygenation.
The primary objective of any analgesia technique is to inhibit the transmission of the pain impulse using an electric stimulus. The Quantum Re-Generation technology, with interchangeable treatment heads for small, localized areas such as the temporomandibular joint or extended areas like the treatment of peripheral nerve canal syndromes such as the Sciatic Nerve, operates through the use of depolarizing high-tension microcurrents, acting on the inhibition of pain by blocking the nociceptors and promoting cellular regeneration.
Effect and Safety
The immediate analgesic effect of the Quantum Re-Generation technology is notable. As chronic pain remodels neural circuits and creates ‘vicious circles’ that amplify suffering, repeated application of this therapy with a complete cycle of multiple sessions can, in turn, remodel these altered sensory circuits, reducing hyper-sensitivity to pain.
To date, the Quantum Re-Generation technology has been extensively tested on patients with various painful musculoskeletal symptoms, neuropathic pain, and even oncological pain with different pathologies.
After just one application, the Quantum Re-Generation technology has proven extremely useful for patients with subacromial conflict syndrome and supra-spinous tendon pain, as well as rotator cuff tendinitis. It has demonstrated effectiveness in inhibiting plantar fasciitis pain caused by calcaneal spurs.
Positive results have been observed in patients with degenerative joint arthrosis with pain and functional limitation, treating all cervical, dorsal, lumbar, and sacro-coccygeal back pain. It has shown very positive results in rheumatoid arthritis and arthrosis of the hand, with a clear reduction in pain and an increase in hand function.
Patients with chronic pain lasting more than six months and acute pain from recent trauma, such as distortive ankle trauma, have also shown positive results. Positive results have been achieved in the treatment of issues of a ligamentous and muscular nature, such as iliotibial band syndrome with pain and limitation of mobility.
The technology has been tested in patients with temporomandibular joint dysfunction, pain at the level of the masticatory muscles due to Bruxism and temporal-mandibular joint pain. In this type of patient, a clear reduction in pain and reduction of hypertonic muscle that generates Bruxism, both concentric and eccentric, has been observed.
The technology has been used in a case of neurological rigidity due to Motor Neuron Disease, Sclerosis Laterale Amiotrofica. The patient showed a significant reduction in hypertonic muscle with a significant improvement in walking.
The Quantum Re-Generation technology has been used as an analgesic therapy in the management of non-opioid-responsive oncological pain, with clear reductions in perceived pain levels. The treatment has been focused on painful bone metastases after Radiotherapy. The technology has also been used in veterinary medicine. Specifically, dogs with degenerative joint arthrosis in their limbs have been treated. Already from the first treatment, the dog has improved its global mobility, indicating a clear reduction in pain. The joint range of motion and walking on all four limbs with complete weight distribution have also improved.
Conclusion
The Quantum Re-Generation technology has been well-tolerated and accepted by all patients, with no side effects of any kind reported. All treated patients have shown a significant reduction in pain. This technology offers a promising approach to managing various types of pain, with potential applications in both human and veterinary medicine.
